GlaxoSmithKline | GSK - PE Price to Earnings



GlaxoSmithKline reported GBP18.27 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Alcon AG 39.04 7.04 Jun/2025
Almirall 79.13 120.6 Jun/2025
Amgen 12.51 28.7 Jun/2025
argenx SE 33.59 13.33 Jun/2025
AstraZeneca 20.04 12.31 Jun/2025
Bayer 6.61 1.6 Jun/2025
Biogen 12.41 0.17 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Eli Lilly 37 7.55 Jun/2025
Fresenius 22.82 1.17 Jun/2025
Fresenius Medical Care 11.22 13.68 Jun/2025
Galapagos 53.92 0 Mar/2025
Genmab 12.13 1.06 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Glaxosmithkline 18.39 3.81 Jun/2025
GRIFOLS 45 27.14 Jun/2025
Hikma Pharmaceutical 19.56 8.4 Jun/2024
Lonza 67.52 12.2 Jun/2024
Merck 13.5 6.24 Jun/2025
Merck 8.58 4.74 Jun/2025
Novartis 15.89 3.03 Jun/2025
Novo Nordisk 17.47 3.29 Jun/2025
Orion 21.59 1.75 Jun/2025
Pfizer 9.12 8.86 Jun/2025
Philips 17.8 13.93 Jun/2025
Recordati 26.71 0.47 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Roche Holding 19.32 1.87 Jun/2024
Sanofi 16.47 6.85 Jun/2025
Smith & Nephew 17.63 17.89 Jun/2025
UCB 156.24 77.45 Jun/2024